Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer
2017 ◽
Vol 99
(2)
◽
pp. E222
2020 ◽
Vol 38
(12)
◽
pp. 906